Versant Venture Management, LLC Ocular Therapeutix, Inc Transaction History

Versant Venture Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$15.82 - $22.11 $23.2 Million - $32.4 Million	-1,465,384 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$7.91 - $22.95 $5.93 Million - $17.2 Million	-750,000 Reduced 33.85%	1,465,384 $30.3 Million
Q3 2017 Oct 13, 2017	BUY	$5.28 - $6.88 $11.7 Million - $15.2 Million	2,215,384	2,215,384 $13.8 Billion

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $641M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Versant Venture Management, LLC with notifications on news.